Geoff Keir

3.6k total citations
50 papers, 2.1k citations indexed

About

Geoff Keir is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Geoff Keir has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 18 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Geoff Keir's work include Traumatic Brain Injury and Neurovascular Disturbances (17 papers), S100 Proteins and Annexins (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Geoff Keir is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (17 papers), S100 Proteins and Annexins (11 papers) and Peripheral Neuropathies and Disorders (10 papers). Geoff Keir collaborates with scholars based in United Kingdom, United States and Slovakia. Geoff Keir's co-authors include Axel Petzold, Edward J. Thompson, Gavin Giovannoni, E J Thompson, Martin Smith, Neil Kitchen, Mary Margaret Kerr, Nick C. Fox, Martin N. Rossor and James A. R. Nicoll and has published in prestigious journals such as Neurology, Stroke and Journal of Neurochemistry.

In The Last Decade

Geoff Keir

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoff Keir United Kingdom 30 1.1k 671 498 432 317 50 2.1k
K Tashiro Japan 30 740 0.7× 705 1.1× 605 1.2× 480 1.1× 132 0.4× 143 2.4k
Hitoshi Kikuchi Japan 24 1.0k 0.9× 673 1.0× 283 0.6× 500 1.2× 433 1.4× 82 2.3k
Hubert Kwieciński Poland 25 1.2k 1.1× 1.4k 2.1× 821 1.6× 666 1.5× 169 0.5× 102 3.3k
Kenji Yoshikawa Japan 27 425 0.4× 550 0.8× 312 0.6× 364 0.8× 324 1.0× 101 2.5k
Setsu Sawai Japan 29 1.4k 1.3× 404 0.6× 794 1.6× 311 0.7× 278 0.9× 88 2.3k
J. J. Gilbert Canada 23 1.7k 1.6× 408 0.6× 856 1.7× 336 0.8× 527 1.7× 50 2.7k
Alessandro Frati Italy 34 1.1k 1.0× 826 1.2× 291 0.6× 351 0.8× 273 0.9× 205 3.8k
Toru Kawanami Japan 30 914 0.8× 688 1.0× 578 1.2× 107 0.2× 235 0.7× 92 2.4k
Naoki Hattori Japan 30 767 0.7× 596 0.9× 616 1.2× 180 0.4× 762 2.4× 115 3.3k
Jangsup Moon South Korea 32 1.5k 1.4× 739 1.1× 335 0.7× 236 0.5× 208 0.7× 166 3.4k

Countries citing papers authored by Geoff Keir

Since Specialization
Citations

This map shows the geographic impact of Geoff Keir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoff Keir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoff Keir more than expected).

Fields of papers citing papers by Geoff Keir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoff Keir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoff Keir. The network helps show where Geoff Keir may publish in the future.

Co-authorship network of co-authors of Geoff Keir

This figure shows the co-authorship network connecting the top 25 collaborators of Geoff Keir. A scholar is included among the top collaborators of Geoff Keir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoff Keir. Geoff Keir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whittam, Daniel, et al.. (2017). What’s new in neuromyelitis optica? A short review for the clinical neurologist. Journal of Neurology. 264(11). 2330–2344. 26 indexed citations
2.
Gnanapavan, Sharmilee, Nasim Yousaf, Wendy Heywood, et al.. (2014). Growth associated protein (GAP-43): Cloning and the development of a sensitive ELISA for neurological disorders. Journal of Neuroimmunology. 276(1-2). 18–23. 7 indexed citations
3.
Baborie, Atik, Timothy D. Griffiths, Evelyn Jaros, et al.. (2012). Frontotemporal Dementia in Elderly Individuals. Archives of Neurology. 69(8). 1052–1052. 31 indexed citations
4.
Tarnaris, Andrew, Ahmed K. Toma, Miles Chapman, et al.. (2010). Rostrocaudal Dynamics of CSF Biomarkers. Neurochemical Research. 36(3). 528–532. 35 indexed citations
5.
Gnanapavan, Sharmilee, et al.. (2010). Neural cell adhesion molecule — Description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders. Journal of Neuroimmunology. 225(1-2). 118–122. 29 indexed citations
6.
Tisdall, Martin, et al.. (2009). Improving the recovery of S100B protein in cerebral microdialysis: Implications for multimodal monitoring in neurocritical care. Journal of Neuroscience Methods. 181(1). 95–99. 15 indexed citations
7.
Wild, Edward J., Axel Petzold, Geoff Keir, & Sarah J. Tabrizi. (2007). Plasma neurofilament heavy chain levels in Huntington's disease. Neuroscience Letters. 417(3). 231–233. 15 indexed citations
8.
Petzold, Axel, Geoff Keir, Jason D. Warren, Nick C. Fox, & Martin N. Rossor. (2007). A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia. Neurodegenerative Diseases. 4(2-3). 185–194. 89 indexed citations
9.
Hawkes, Christopher H., Gavin Giovannoni, Geoff Keir, Marianne Cunnington, & E. J. Thompson. (2006). Seroprevalence of herpes simplex virus type 2 in multiple sclerosis. Acta Neurologica Scandinavica. 114(6). 363–367. 17 indexed citations
10.
Keir, Geoff, et al.. (2005). Antigenic differences between neurological and diabetic patients with anti‐glutamic acid decarboxylase antibodies. European Journal of Neurology. 12(4). 294–299. 40 indexed citations
11.
Sen, Jon, Antonio Belli, Axel Petzold, et al.. (2005). Extracellular fluid S100B in the injured brain: a future surrogate marker of acute brain injury?. Acta Neurochirurgica. 147(8). 897–900. 26 indexed citations
12.
Vianello, Marika, Roberta Vitaliani, Raffaele Pezzani, et al.. (2004). The spectrum of antineuronal autoantibodies in a series of neurological patients. Journal of the Neurological Sciences. 220(1-2). 29–36. 28 indexed citations
13.
Rejdak, Konrad, Axel Petzold, Martyn A. Sharpe, et al.. (2004). Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage. Journal of the Neurological Sciences. 219(1-2). 71–76. 21 indexed citations
14.
Petzold, Axel, et al.. (2003). Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Research Bulletin. 61(3). 281–285. 107 indexed citations
15.
Petzold, Axel, Rosemary Jenkins, Hilary Watt, et al.. (2003). Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neuroscience Letters. 336(3). 167–170. 91 indexed citations
16.
Petzold, Axel, Alison J. E. Green, Geoff Keir, et al.. (2002). Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study. Critical Care Medicine. 30(12). 2705–2710. 81 indexed citations
17.
Villar, Luisa María, P. González-Porqué, Jaime Masjuán, et al.. (2001). A sensitive and reproducible method for the detection of oligoclonal IgM bands. Journal of Immunological Methods. 258(1-2). 151–155. 63 indexed citations
18.
Brydon, Howard L., et al.. (1998). Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. Journal of Neurology Neurosurgery & Psychiatry. 64(5). 643–647. 30 indexed citations
19.
Deisenhammer, Florian, Geoff Keir, Bettina Pfausler, & E J Thompson. (1996). Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients. Journal of Neuroimmunology. 66(1-2). 85–93. 21 indexed citations
20.
Keir, Geoff, Nilgun Tasdemir, & Edward J. Thompson. (1993). Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clinica Chimica Acta. 216(1-2). 153–166. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Tashiro Breakdown of academic impact, for papers by Hitoshi Kikuchi Breakdown of academic impact, for papers by Hubert Kwieciński Breakdown of academic impact, for papers by Kenji Yoshikawa Breakdown of academic impact, for papers by Setsu Sawai Breakdown of academic impact, for papers by J. J. Gilbert Breakdown of academic impact, for papers by Alessandro Frati Breakdown of academic impact, for papers by Toru Kawanami Breakdown of academic impact, for papers by Naoki Hattori Breakdown of academic impact, for papers by Jangsup Moon
Rankless by CCL
2026